GRANULES INDIA share price has plunged 3% and is presently trading at Rs 664.1.
Meanwhile, the BSE HEALTHCARE index is at 43,328.7 (down 0.3%).
Among the top losers in the BSE HEALTHCARE index today are AJANTA PHARMA (down 2.1%) and MAX HEALTHCARE INSTITUTE (down 2.0%).
ALEMBIC PHARMA (up 4.8%) and HIKAL CHEMIC (up 2.7%) are among the top gainers today.
Over the last one year, GRANULES INDIA has moved up from Rs 311.3 to Rs 664.1, registering a gain of Rs 352.8 (up 113.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,328.7, registering a gain of 53.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 139.3%), Glenmark Pharma (up 116.8%) and GRANULES INDIA (up 113.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,079.0 (down 0.1%).
The top losers among the BSE Sensex today are Tata Steel (down 1.3%) and Power Grid Corp. (down 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,813.7 (down 0.2%). ONGC and Tata Steel are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,079.0, registering a gain of 15,298.8 points (up 23.3%).
GRANULES INDIA net profit grew 181.1% YoY to Rs 1,346 million for the quarter ended June 2024, compared to a profit of Rs 479 million a year ago. Net sales rose 19.7% to Rs 11,799 million during the period as against Rs 9,855 million in April-June 2023.
For the year ended March 2024, GRANULES INDIA reported 21.5% decrease in net profit to Rs 4,053 million compared to net profit of Rs 5,166 million during FY23. Revenue of the company fell 0.1% to Rs 45,064 million during FY24.
The current Price to earnings ratio of GRANULES INDIA, based on rolling 12 month earnings, stands at 32.7.
Equitymaster requests your view! Post a comment on "GRANULES INDIA Plunges 3%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!